We are pleased to announce that 4P-Pharma is among the Top 100 start-ups selected to participate in the 3rd edition of Big Booster, an international non-profit acceleration program for startups. We are looking forward to meet all the Big Booster actors at the Lyon Booster Camp November 14th-16th. During this event we will be presenting&hellip
Our BD team will attend the next BPI Innogeneration on thursday october 12th. If you would like to discuss about potential collaboration and early-stage technologies in the field of oncology and inflammation, do not hesitate to contact us: contact at 4p-pharma.com See you there!
4P-Pharma is a recognized actor in the ADHD pipeline drug development. Stimulant abuse and addiction is a major global health problem and prescription drugs are indeed more and more abused, in virtue of their “rewarding” psychotropic effects. ADHD medications abuse increased by 4 fold, and led to a 400% increased in emergency room visits from&hellip
At the invitation of the Luxembourg Institute of Health, Revital Rattenbach, CEO of 4P-Pharma, will be giving a presentation at the Institute on July 12th. This talk is part of the lecture series biomedical research organized by the LIH. Lecture Series Biomedical Research: from discovery to patients : Key Factors in Preclinical and Early&hellip
4P-Pharma a été invitée à rejoindre le réseau business Bpifrance Excellence. Ce réseau regroupe 4000 entreprises françaises innovantes dans des aires très variées: digital, santé, alimentaire, automobile. Le réseau permet à ses membres d’échanger entre eux à travers d’une plateforme en ligne, de bénéficier de propositions de business, et d’événements Bpifrance Excellence.
4P-Pharma was selected to give a pitch at the Pierre Fabre DayONE open innovation day on June 14th in Toulouse. The one day conference aim is to identify, and develop innovative projects from biopharmaceutical companies, start-ups, and research laboratories (public or private) specialized in oncology, dermatology or consumer healthcare.